NASDAQ

MiNK Therapeutics, Inc. (INKT)

♥ 563 Thanks from members

Live price chart, market sentiment, and community perspectives for MiNK Therapeutics, Inc. (NASDAQ: INKT).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: Health CareIndustry: BiotechnologyFounder: NKT TherapeuticsFounder: SanlejLeadership: Porous M. Cooper (CEO)Holder: Protalix BioTherapeuticsHolder: Institutional InvestorsAGEN1734 pipelineproprietary iNKT cell platform#INKT#MiNK Therapeutics#iNKT Cells#Biotech#NASDAQ